pyrimidine has been researched along with cyclin d1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos, JM; Conejo-García, A; Cruz-López, O; Díaz-Gavilán, M; Espinosa, A; Gallo, MA; Núñez, MC | 1 |
| Bhatnagar, PK; Dastidar, SG; Kapoor, S; Nithya, D; Ray, A; Senthil, V; Sharma, A; Talwadkar, A; Tandon, R; Vali, S; Venkataramanan, R | 1 |
| Aboagye, EO; Ali, S; Barrett, AG; Bondke, A; Carroll, L; Coombes, RC; Delaney, S; Fuchter, MJ; Heathcote, DA; Kaliszczak, M; Kroll, SH; Patel, H; Smith, G | 1 |
| Abbas, SE; Abdel-Aziz, HA; Abou-Seri, SM; Eladwy, RA; Fares, M; Youssef, MM | 1 |
1 review(s) available for pyrimidine and cyclin d1
| Article | Year |
|---|---|
Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines.
Topics: Acetals; Antineoplastic Agents; Benzene Derivatives; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Design; Fluorouracil; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Neoplasm Metastasis; Purines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
3 other study(ies) available for pyrimidine and cyclin d1
| Article | Year |
|---|---|
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment.
Topics: Amino Acid Sequence; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Computational Biology; Cyclin D1; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Humans; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Receptor, IGF Type 1 | 2011 |
Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Cell Membrane Permeability; Cyclin D1; Cyclin-Dependent Kinases; Down-Regulation; Drug Resistance, Neoplasm; Female; G2 Phase; HCT116 Cells; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Xenograft Model Antitumor Assays | 2013 |
Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Pyrimidines; Triazoles | 2014 |